Evidence map›Paper›PMID 41177862›Full record

ArticleJournal of applied genetics2025

Familial hyponatremia conditioned by the R137C mutation with constitutive activation of the vasopressin receptor.

Hanna Szymanik-Grzelak, Maria Daniel, Małgorzata Pańczyk-Tomaszewska

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of applied genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hanna Szymanik-GrzelakDepartment of Pediatrics and Nephrology, Medical University of Warsaw, Warsaw, Poland.
Maria DanielDepartment of Pediatrics and Nephrology, Medical University of Warsaw, Warsaw, Poland. maria.daniel@wum.edu.pl.ORCID http://orcid.org/0000-0002-6525-0882
Małgorzata Pańczyk-TomaszewskaDepartment of Pediatrics and Nephrology, Medical University of Warsaw, Warsaw, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hyponatremia can occur in endocrinological diseases, neoplasms, kidney diseases, and acquired or genetically conditioned disorders of antidiuretic hormone levels. Nephrogenic syndrome of inappropriate antidiuresis (NSIAD) is a rare X-linked disease caused by a point mutation of the type 2 vasopressin receptor (AVPR2) gene. This mutation results in constitutive activation of the AVPR2 and a low sodium level.We reported the first familial NSIAD in Poland in siblings with hyponatremia. Case 1. A 2.5-year-old boy, during a respiratory tract infection, showed the following laboratory test results: Na 125 mmol/L, serumosmolality 260 mOsm/kg H2O, low uric acid level, and increased fractional sodium and uric acid excretions. Thyroid, adrenal, and renal function were normal. Copeptin level was low. Case 2. A 7-month-old brother presented with reduced activity and muscle tone, a sodium level of 117 mmol/L, and a serum osmolality of 249 mOsm/kg H2O. They were both confirmed to be hemizygous for the R137C mutation on the AVPR2 gene. The boys were advised to restrict their oral fluid intake and supplement sodium orally, aiming for sodium levels of 133-140 mmol/L. Conclusions: Genetic testing for an AVPR2 mutation is crucial in patients with hyponatremia, normovolemia, hypoosmolality, and low copeptin level.

Indexed as

AVPR2ChildrenHyponatremiaNSIADp.Arg137Cys

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.